PATHOPHYSIOLOGY • ENDOCRINE AND METABOLIC PATHOPHYSIOLOGY

Hyperthyroidism vs. Hypothyroidism

Understanding how excess and deficient thyroid hormone production drive opposing clinical syndromes through shared feedback mechanisms.

Historical Context & Motivation

Thyroid disease has been recognized for millennia, though the underlying pathophysiology was elucidated only within the past two centuries. Ancient physicians described goiter — visible enlargement of the thyroid gland — as early as 2700 BCE in Chinese medical texts, and Roman authors noted that neck swelling was endemic in Alpine populations. However, the functional significance of the thyroid gland remained obscure until surgeons and endocrinologists began to connect glandular anatomy with metabolic regulation. The parallel discovery of hyperthyroid and hypothyroid states revealed that a single gland could produce diametrically opposed clinical syndromes, depending on whether hormone output was excessive or deficient. This historical arc illustrates a broader principle in endocrine pathophysiology: that hormonal homeostasis depends on tightly regulated feedback loops, and disruption in either direction carries distinct pathological consequences.

1835
Robert Graves Describes Exophthalmic Goiter
Irish physician Robert Graves published clinical descriptions of patients with diffuse goiter, tachycardia, and exophthalmos, establishing what would become known as Graves disease — the most common cause of hyperthyroidism.
1878
Myxedema Linked to Thyroid Atrophy
William Ord coined the term myxedema to describe the severe form of hypothyroidism characterized by non-pitting edema, hypothermia, and altered mental status, recognizing its association with thyroid gland degeneration.
1891
First Thyroid Hormone Replacement Therapy
George Murray successfully treated myxedema by injecting sheep thyroid extract, demonstrating that thyroid deficiency was a correctable hormonal deficit and inaugurating the era of hormone replacement.
1952
Identification of TSH Receptor Antibodies
Adams and Purves identified a long-acting thyroid stimulator (LATS) in the serum of Graves patients — later characterized as thyroid-stimulating immunoglobulin (TSI) — establishing the autoimmune basis of hyperthyroidism.
1956
Hashimoto Thyroiditis Recognized as Autoimmune
Deborah Doniach and Ivan Roitt demonstrated antithyroid antibodies in Hashimoto thyroiditis, confirming it as the prototypical autoimmune cause of hypothyroidism and linking both major thyroid disorders to immune dysregulation.

The central question that unifies these historical milestones is deceptively simple: how does a single butterfly-shaped gland in the anterior neck produce two fundamentally opposite disease states? Answering this question requires understanding the hypothalamic-pituitary-thyroid (HPT) axis, the biochemistry of thyroid hormone synthesis, and the downstream metabolic effects that make thyroid dysfunction one of the most commonly encountered endocrine disorders in clinical practice.

Core Principles & Definitions

Before comparing hyperthyroidism and hypothyroidism, it is essential to establish the physiological framework that governs thyroid function. The thyroid gland synthesizes two principal hormones — thyroxine (T₄) and triiodothyronine (T₃) — from the amino acid tyrosine and dietary iodine. T₄ is the predominant circulating form, but T₃ is the biologically active hormone, generated largely through peripheral deiodination of T₄ by type 1 and type 2 deiodinase enzymes in the liver, kidneys, and target tissues. The regulation of thyroid hormone output depends on a classic negative feedback loop involving the hypothalamus, anterior pituitary, and thyroid gland.

1

HPT Axis & Negative Feedback

The hypothalamus secretes thyrotropin-releasing hormone (TRH), which stimulates the anterior pituitary to release thyroid-stimulating hormone (TSH). TSH activates thyroid follicular cells. Elevated T₃/T₄ feeds back to suppress both TRH and TSH secretion.
2

Hyperthyroidism: Hormone Excess

Hyperthyroidism denotes a state of excess circulating thyroid hormone, resulting in a hypermetabolic syndrome. The term thyrotoxicosis is broader, encompassing any cause of elevated thyroid hormones, including exogenous ingestion and gland destruction.
3

Hypothyroidism: Hormone Deficiency

Hypothyroidism results from inadequate thyroid hormone production or action, leading to a hypometabolic state. It is classified as primary (thyroid gland failure), secondary (pituitary TSH deficiency), or tertiary (hypothalamic TRH deficiency).
4

Primary vs. Secondary Classification

In primary disorders, the pathology resides in the thyroid gland itself; TSH levels move in the opposite direction of thyroid hormones due to intact feedback. In secondary/tertiary disorders, the pituitary or hypothalamus is dysfunctional, and TSH may be inappropriately low or normal.
5

Subclinical States

Subclinical hyperthyroidism features suppressed TSH with normal free T₃/T₄. Subclinical hypothyroidism features elevated TSH with normal free T₃/T₄. These states may progress to overt disease and carry their own cardiovascular and skeletal risks.
KEY TAKEAWAY
Think of the HPT axis like a thermostat system in a building. The hypothalamus is the thermostat setting a target temperature, the pituitary is the control unit that sends the 'heat on' signal (TSH), and the thyroid is the furnace producing heat (T₃/T₄). In hyperthyroidism, the furnace runs uncontrollably despite the thermostat signaling it to stop — the house overheats. In hypothyroidism, the furnace is broken; the thermostat keeps sending louder signals (elevated TSH), but the house stays cold. Understanding this feedback loop is the key to interpreting thyroid function tests and distinguishing primary from central disease.

The HPT Axis: Visual Explanation

The HPT axis operates via a classic negative feedback loop. TRH from the hypothalamus stimulates TSH release from the anterior pituitary, which in turn drives T₃/T₄ synthesis by the thyroid gland. Elevated thyroid hormones feed back to suppress both TRH and TSH secretion (dashed red lines). In primary hyperthyroidism, autonomous hormone production suppresses TSH. In primary hypothyroidism, gland failure results in compensatory TSH elevation.

The diagram above illustrates the central organizing principle of thyroid pathophysiology. When interpreting thyroid function tests, clinicians rely on the inverse relationship between TSH and free thyroid hormone levels that characterizes primary thyroid disorders. A suppressed TSH with elevated free T₄ points to hyperthyroidism, while an elevated TSH with low free T₄ confirms primary hypothyroidism. This pattern breaks down in central (secondary) disorders, where pituitary or hypothalamic dysfunction results in inappropriately normal or low TSH despite low circulating hormones. A TSH-secreting pituitary adenoma, though rare, can produce the paradoxical combination of elevated TSH with elevated free T₄ — underscoring the importance of clinical context when interpreting laboratory data.

Pathophysiological Mechanisms

Mechanisms of Hyperthyroidism

The pathogenesis of hyperthyroidism can be classified by whether the thyroid gland is actively synthesizing excess hormone or passively releasing preformed hormone from damaged follicles. In the first category, Graves disease is the most prevalent cause, accounting for 60–80% of hyperthyroidism cases. IgG autoantibodies (thyroid-stimulating immunoglobulins, TSI) bind to and activate the TSH receptor on follicular cells, mimicking TSH but escaping negative feedback regulation. The result is uncontrolled synthesis and secretion of T₃ and T₄, diffuse thyroid enlargement, and extrathyroidal manifestations including Graves ophthalmopathy (caused by cross-reactive antibodies targeting TSH receptors on orbital fibroblasts) and pretibial myxedema. Toxic multinodular goiter and toxic adenoma arise from somatic activating mutations in the TSH receptor or Gsα subunit, leading to constitutive cAMP signaling in a subset of thyroid cells that function autonomously.

In the second category, destructive thyroiditis (subacute, postpartum, or painless thyroiditis) damages follicular architecture, releasing stored hormone into the circulation. This thyrotoxicosis without hyperthyroidism is typically self-limited and is distinguished by low radioactive iodine uptake (RAIU) on thyroid scintigraphy, in contrast to the elevated RAIU seen in Graves disease and toxic nodular disease. The distinction is clinically important because destructive thyroiditis does not respond to antithyroid drugs and may transition through a hypothyroid phase as hormone stores are depleted before recovery.

Mechanisms of Hypothyroidism

Primary hypothyroidism accounts for over 95% of cases and reflects intrinsic thyroid gland failure. The most common etiology worldwide is iodine deficiency, while in iodine-sufficient regions, Hashimoto thyroiditis (chronic lymphocytic thyroiditis) predominates. In Hashimoto disease, CD4⁺ T-helper cells, cytotoxic CD8⁺ T cells, and autoantibodies — including anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies — orchestrate progressive follicular destruction, fibrosis, and eventual gland atrophy. Iatrogenic causes include thyroidectomy, radioactive iodine ablation for Graves disease, and external beam radiation to the neck. Certain medications, notably amiodarone (which contains 37% iodine by weight) and lithium, can induce hypothyroidism through distinct mechanisms.

At the cellular level, thyroid hormone deficiency impairs basal metabolic rate by reducing expression of Na⁺/K⁺-ATPase, mitochondrial uncoupling proteins, and β-adrenergic receptors across multiple organ systems. This produces the classic hypometabolic phenotype — bradycardia, cold intolerance, weight gain, constipation, and cognitive slowing. The accumulation of glycosaminoglycans (particularly hyaluronic acid) in the dermal interstitium creates the characteristic non-pitting myxedematous skin changes. In severe or prolonged cases, myxedema coma can develop, representing a life-threatening decompensation with hypothermia, hypoventilation, hyponatremia, and altered consciousness.

💊 Clinical Pearl
Amiodarone can cause both hyperthyroidism and hypothyroidism. Type 1 amiodarone-induced thyrotoxicosis occurs in patients with underlying thyroid disease due to iodine excess (Jod-Basedow effect), while Type 2 results from direct drug-induced destructive thyroiditis. This dual capacity exemplifies how a single pharmacologic agent can push the thyroid axis in either direction depending on the patient's underlying susceptibility.

Clinical Features & Classification

The clinical manifestations of hyperthyroidism and hypothyroidism represent mirror images of thyroid hormone's effects on metabolism, the cardiovascular system, the nervous system, and the integumentary system. A systematic comparison of these features is invaluable for clinical reasoning, as many of the signs and symptoms derive directly from the underlying pathophysiology of thyroid hormone excess or deficiency.

This side-by-side comparison organizes the clinical manifestations of hyperthyroidism and hypothyroidism by organ system. Note the mirror-image pattern: thyroid hormone excess accelerates metabolic processes across every system, while deficiency decelerates them. The laboratory findings row at the bottom summarizes the characteristic lab profile for each condition.

Several features deserve special emphasis. The cardiovascular effects of thyroid hormone excess reflect both direct genomic effects on cardiac myocytes (upregulation of β₁-adrenergic receptors and myosin heavy chain α isoform) and hemodynamic changes (decreased systemic vascular resistance, increased blood volume). Atrial fibrillation occurs in 10–15% of hyperthyroid patients and is a major source of morbidity. In contrast, hypothyroidism increases systemic vascular resistance and can cause diastolic hypertension and accelerated atherosclerosis via hypercholesterolemia. The delayed relaxation phase of deep tendon reflexes ("hung-up" reflexes) is a classic physical examination finding in hypothyroidism, resulting from slowed skeletal muscle contraction and relaxation kinetics.

Worked Example: Diagnostic Reasoning

The following clinical vignette demonstrates the systematic approach to diagnosing thyroid dysfunction, integrating history, physical examination, laboratory data, and imaging.

Case: A 32-Year-Old Woman with Palpitations and Weight Loss
1
Step 1 — Obtain History & Identify Key SymptomsA 32-year-old woman presents with a 3-month history of unintentional weight loss (8 kg), heat intolerance, palpitations, hand tremor, and increased stool frequency. She notes anxiety, insomnia, and menstrual irregularity (oligomenorrhea). She has no significant past medical history and takes no medications. Family history is notable for a maternal aunt with 'thyroid problems.' These symptoms — weight loss with increased appetite, heat intolerance, tremor, and tachycardia — form a classic hypermetabolic syndrome suggestive of thyrotoxicosis.
Clinical suspicion: hyperthyroidism
2
Step 2 — Perform Targeted Physical ExaminationExamination reveals a resting heart rate of 108 bpm, a blood pressure of 148/62 mmHg (wide pulse pressure), fine tremor of outstretched hands, warm moist skin, and lid lag. The thyroid gland is diffusely enlarged, non-tender, and a bruit is auscultated over the gland. Bilateral proptosis is noted. The presence of diffuse goiter with a bruit and ophthalmopathy is highly suggestive of Graves disease, as these extrathyroidal findings are not seen in toxic nodular disease or thyroiditis.
Physical exam supports: Graves disease
3
Step 3 — Order and Interpret Thyroid Function TestsLaboratory results show: TSH < 0.01 mIU/L (reference: 0.4–4.0), Free T₄ = 4.8 ng/dL (reference: 0.8–1.8), Free T₃ = 12.4 pg/mL (reference: 2.3–4.2). The profoundly suppressed TSH with elevated free T₄ and T₃ confirms overt primary hyperthyroidism. The suppressed TSH reflects intact negative feedback at the pituitary level in response to excess circulating thyroid hormones.
TSH < 0.01, Free T₄ ↑↑, Free T₃ ↑↑ → Overt hyperthyroidism confirmed
4
Step 4 — Determine Etiology with Additional TestingTSH receptor antibodies (TRAb/TSI) are ordered and return strongly positive. A radioactive iodine uptake (RAIU) scan shows diffusely elevated uptake at 65% at 24 hours (normal: 10–30%). This diffuse pattern with elevated uptake distinguishes Graves disease from toxic multinodular goiter (patchy uptake) and thyroiditis (low uptake). In this case, the combination of clinical findings (ophthalmopathy), positive TSI antibodies, and diffuse elevated RAIU provides a definitive diagnosis of Graves disease.
Final diagnosis: Graves disease with ophthalmopathy
5
Step 5 — Initiate Management and MonitorTreatment options include antithyroid drugs (methimazole first-line, with propylthiouracil reserved for first trimester pregnancy and thyroid storm), radioactive iodine ablation, or thyroidectomy. Given her age and ophthalmopathy (which may worsen after RAI without steroid prophylaxis), the clinician discusses methimazole with a beta-blocker (propranolol) for symptomatic relief. TSH is monitored every 4–6 weeks during dose titration. The target is normalization of free T₄ and T₃, with eventual TSH recovery from its suppressed state. Patients should be counseled that RAI therapy and surgery will result in iatrogenic hypothyroidism requiring lifelong levothyroxine replacement.
Plan: Methimazole + propranolol; monitor TFTs q4–6 weeks; ophthalmology referral

Diagnostic Approach & Comparison

The diagnostic evaluation of suspected thyroid dysfunction follows a systematic algorithm anchored by the initial TSH measurement. Because TSH has a log-linear relationship with free T₄ — a twofold change in free T₄ produces an approximately 100-fold change in TSH — serum TSH is the most sensitive screening test for primary thyroid disorders. The following table compares the diagnostic workup, laboratory patterns, and key differentiating features for the major causes of hyperthyroidism and hypothyroidism.

Diagnostic comparison of hyperthyroidism and hypothyroidism
FeatureHyperthyroidismHypothyroidism
Initial screening testSerum TSH (expected: suppressed < 0.1 mIU/L)Serum TSH (expected: elevated > 4.0–10 mIU/L)
Confirmatory testsFree T₄, Free T₃ (both elevated in overt disease; T₃ may be selectively elevated in T₃ thyrotoxicosis)Free T₄ (low in overt disease; normal in subclinical hypothyroidism)
Etiologic workupTSI/TRAb antibodies, RAIU scan, thyroid ultrasoundAnti-TPO antibodies, anti-thyroglobulin antibodies, thyroid ultrasound
Most common causeGraves disease (diffuse ↑ RAIU, TSI-positive)Hashimoto thyroiditis (anti-TPO positive, heterogeneous hypoechoic gland on ultrasound)
Lipid profile↓ Total cholesterol, ↓ LDL (accelerated hepatic LDL receptor expression)↑ Total cholesterol, ↑ LDL (decreased hepatic LDL clearance)
CBC findingsNormocytic anemia possible; lymphocytosis in GravesMacrocytic anemia (impaired folate metabolism, concurrent pernicious anemia)
Emergency presentationThyroid storm: fever >40°C, delirium, tachyarrhythmias, multiorgan failureMyxedema coma: hypothermia, hypoventilation, hyponatremia, obtundation
KEY TAKEAWAY
Think of TSH as the 'amplifier signal' in the feedback loop — it is exquisitely sensitive to small changes in thyroid hormone levels, much like a seismograph that registers tremors too subtle for human perception. This is why TSH is the preferred screening test: even early, subclinical thyroid dysfunction will alter TSH well before free T₄ moves outside the normal range. The mnemonic 'TSH and T₄ go in opposite directions in primary disease' is the single most important diagnostic principle in thyroid pathophysiology. When TSH and free T₄ move in the same direction — both high or both low — suspect a central (pituitary/hypothalamic) etiology.

Connection to Advanced Endocrine Pathology

Mastery of thyroid pathophysiology provides a conceptual scaffold for understanding more complex endocrine disorders. The principles of negative feedback disruption, autoimmune gland destruction versus stimulation, and subclinical-to-overt disease progression apply broadly across endocrine axes. The following table connects core thyroid concepts to advanced topics that students will encounter in clinical rotations and board examinations.

Bridging thyroid pathophysiology to advanced endocrine topics
Thyroid ConceptAdvanced ConnectionClinical Relevance
TSI-mediated Graves diseaseType V hypersensitivity (stimulatory autoimmunity), analogous to anti-TSHR blocking antibodies in atrophic thyroiditisSame receptor, opposite antibody effects — stimulatory vs. blocking — producing opposite clinical syndromes
Hashimoto-to-Graves transitionAutoimmune polyendocrine syndromes (APS-2: thyroiditis + adrenal insufficiency + type 1 DM)Screen for coexisting autoimmune conditions; approximately 10% of Hashimoto patients have concurrent autoimmune disease
Subclinical thyroid diseaseCardiovascular risk stratification: subclinical hypothyroidism increases coronary artery disease risk; subclinical hyperthyroidism increases atrial fibrillation and osteoporosis riskTreatment thresholds remain debated; TSH >10 mIU/L generally warrants treatment
Thyroid nodules in Graves/HashimotoThyroid malignancy (papillary thyroid carcinoma has ↑ incidence in Hashimoto); FNA biopsy, Bethesda classification, molecular testingAll thyroid nodules >1 cm require evaluation regardless of functional status
Thyroid hormone resistanceResistance to thyroid hormone (RTH): mutations in TRβ gene produce elevated T₃/T₄ with unsuppressed TSHMimics TSH-secreting adenoma; distinguish by family history, genetic testing, absence of pituitary mass

An emerging area of investigation is the role of thyroid dysfunction in non-thyroidal illness syndrome (NTIS), formerly called 'euthyroid sick syndrome,' in which critically ill patients exhibit low T₃, variable T₄, and inappropriately normal or low TSH without intrinsic thyroid disease. The pathogenesis involves cytokine-mediated suppression of the HPT axis and altered peripheral deiodination, and it illustrates the complexity of interpreting thyroid function tests outside the ambulatory setting. Whether treating NTIS with thyroid hormone replacement improves outcomes in ICU patients remains an active area of clinical research.

Practice Problems

PROBLEM 1CONCEPTUAL
A patient with primary hypothyroidism has a serum TSH of 45 mIU/L (reference: 0.4–4.0) and a free T₄ of 0.3 ng/dL (reference: 0.8–1.8). Explain why the TSH is elevated while the free T₄ is low. What would you expect the TSH and free T₄ values to look like if this patient instead had secondary hypothyroidism due to a pituitary adenoma compressing thyrotrophs?
PROBLEM 2BASIC CALCULATION
A patient's thyroid function tests reveal: TSH = 0.02 mIU/L, Free T₄ = 5.2 ng/dL, Free T₃ = 14.8 pg/mL. The radioactive iodine uptake (RAIU) at 24 hours is 58% (normal: 10–30%). Based on these values, what is the most likely diagnosis? How would the RAIU differ if the patient had subacute thyroiditis instead?
PROBLEM 3INTERMEDIATE
A 55-year-old man on amiodarone for atrial fibrillation develops new-onset thyrotoxicosis. His interleukin-6 (IL-6) is markedly elevated, and color-flow Doppler ultrasonography of the thyroid shows absent vascularity. The RAIU is <2%. Is this Type 1 or Type 2 amiodarone-induced thyrotoxicosis (AIT)? Justify your answer by explaining the pathophysiological mechanism and how it influences treatment.
PROBLEM 4APPLIED
A 28-year-old woman who is 8 weeks pregnant presents with nausea, vomiting, tachycardia, and a TSH of 0.08 mIU/L with a mildly elevated free T₄. She has no history of thyroid disease, no goiter, and negative TSI antibodies. Her hCG level is 120,000 mIU/mL (elevated for gestational age). Explain the pathophysiology of her thyrotoxicosis and discuss why methimazole would not be the first-line treatment if pharmacotherapy were needed.
PROBLEM 5CRITICAL THINKING
A patient presents with the following thyroid function tests: TSH = 8.5 mIU/L (elevated), Free T₄ = 3.6 ng/dL (elevated), Free T₃ = 9.2 pg/mL (elevated). This 'discordant' pattern — elevated TSH alongside elevated thyroid hormones — defies the expected inverse relationship in primary disease. Develop a differential diagnosis and explain the pathophysiological basis for each possibility.

Lesson Summary

Hyperthyroidism and hypothyroidism represent the two poles of thyroid dysfunction, both governed by the hypothalamic-pituitary-thyroid (HPT) axis and its negative feedback loops. The most common causes are autoimmune: Graves disease drives hyperthyroidism through stimulatory TSH receptor antibodies (TSI), while Hashimoto thyroiditis causes hypothyroidism through immune-mediated follicular destruction. The clinical manifestations are mirror images: hyperthyroidism produces a hypermetabolic state (tachycardia, weight loss, heat intolerance, tremor, hyperreflexia), while hypothyroidism produces a hypometabolic state (bradycardia, weight gain, cold intolerance, fatigue, delayed reflexes).

Diagnosis begins with serum TSH as the most sensitive screening test, followed by free T₄ and free T₃ for confirmation. In primary disease, TSH and thyroid hormones move in opposite directions; when they move in the same direction, suspect central (secondary/tertiary) disease or rare entities such as TSH-secreting adenomas and thyroid hormone resistance. Etiologic workup utilizes thyroid autoantibodies (TSI, anti-TPO) and radioactive iodine uptake to differentiate between etiologies. Management of hyperthyroidism includes antithyroid drugs, radioactive iodine ablation, or thyroidectomy, while hypothyroidism is treated with levothyroxine replacement titrated to normalize TSH. Understanding these opposing syndromes through a unified pathophysiological framework equips clinicians to diagnose accurately, treat effectively, and anticipate complications across the full spectrum of thyroid disease.

Varsity Tutors • Pathophysiology • Hyperthyroidism vs. Hypothyroidism